Antimicrobial Stewardship and Cattle Welfare

Key Welfare Considerations

• Antimicrobial resistance (AMR) poses an existential threat to human and animal welfare globally.
• Cattle farming uses significant antibiotic volumes — responsible use balances welfare treatment needs with AMR prevention.
• RUMA (Responsible Use of Medicines in Agriculture) guidelines provide welfare-appropriate prescribing frameworks.
• Critically Important Antibiotics (CIAs) including 3rd/4th generation cephalosporins and fluoroquinolones should be restricted.
• CIA restriction in cattle has been achieved in the UK without welfare compromise through improved prevention.
• Preventive medicine through vaccination, nutrition, and biosecurity reduces antibiotic treatment welfare need.
• Metaphylactic treatment (mass treatment of at-risk groups) requires careful welfare-AMR benefit assessment.
• Targeted selective treatment using diagnostic testing improves antibiotic precision for welfare and AMR.
• Farm health plans with vets integrating welfare and AMR objectives improve overall outcomes.
• Antibiotic treatment records enable monitoring of welfare disease patterns and antimicrobial use trends.
• Alternative welfare interventions including probiotics, botanicals, and vaccines are being developed.
• Dry cow therapy review — selective rather than blanket treatment — reduces antibiotic use without welfare compromise.
• Teat sealants as an alternative to antibiotic dry cow therapy protect welfare through mastitis prevention.
• National Antibiotic Guardian targets for cattle farming drive welfare-compatible reduction programmes.
• The One Health framework recognises that human, animal, and environmental welfare are interconnected through AMR.